Clinical Trial Update: Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212) [Phase 3]

View source ↗

Summary

A phase 3 trial comparing mesorectal excision alone versus mesorectal excision with lateral node dissection in stage II–III lower rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Haruhiko Fukuda | Conditions: Rectal Neoplasms | Phase 3 | Status: COMPLETED